Common Stock Reserved For Issuance

12 Months Ended

Dec. 31, 2020

Equity [Abstract]

Common Stock Reserved For Issuance

10. COMMON STOCK RESERVED FOR ISSUANCE

Common stock has been reserved for the following potential future issuances:

	As of December 31, 2020		As of December 31, 2019
Shares underlying outstanding stock options		832,868		579,731
Shares available for future stock option grants		267,275		230,952
Exchange of Vaccinex Products, LP units		1,147,259		1,173,500
Conversion of VX3 units		1,318,797		1,318,797
Total shares of common stock reserved		3,566,199		3,302,980

During the years ended December 31, 2020 and 2019, 26,241 and 29,066 units, respectively, of Vaccinex Products, LP were exchanged for shares of the Company’s common stock at par value of $0.0001 per share.